Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury

Keyphrases

• Poly(ADP-ribose) Synthetase 100%
• Intratracheal 100%
• Reperfusion 100%
• Lung Ischemia-reperfusion Injury 100%
• Activator protein-1 (AP-1) 60%
• Nuclear Translocation 40%
• Lung 40%
• Vascular Permeability 40%
• Monocyte Chemoattractant protein-1 (MCP-1) 40%
• Left Lung 40%
• INO-1001 40%
• Cytokine-induced Neutrophil chemoattractant-1 40%
• Albumin 20%
• Lung Injury 20%
• Ischemia 20%
• Chemokines 20%
• Electrophoretic Mobility Shift Assay 20%
• Bronchoalveolar Lavage Fluid 20%
• In Situ 20%
• Myeloperoxidase Activity 20%
• Myeloperoxidase 20%
• Donor Organs 20%
• Equivalent Volume 20%
• Leukocyte Count 20%
• Alveoli 20%
• Leukocyte Accumulation 20%
• Hilar 20%
• Recipient Outcomes 20%
• Occlusion Model 20%
• Secreted Cytokine 20%

Medicine and Dentistry

• Poly ADP Ribose Polymerase 100%
• Reperfusion Injury 100%
• Lung 100%
• Leukocyte 40%
• Blood Vessel Permeability 40%
• Left Lung 40%
• Myeloperoxidase 40%
• Cytokine Induced Neutrophil Chemoattractant 40%
• Secretion (Process) 20%
• Chemokine 20%
• Gel Mobility Shift Assay 20%
• Enzyme Linked Immunosorbent Assay 20%
• PARP Inhibitor 20%
• Ischemia 20%
• Bronchoalveolar Lavage Fluid 20%
• Organ Donor 20%
• Cell Count 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Synthetase 100%
• Poly(adenosine Diphosphate Ribose) 100%
• Reperfusion Injury 100%
• Myeloperoxidase 66%
• Cytokine Induced Neutrophil Chemoattractant 66%
• Enzyme-Linked Immunosorbent Assay 33%
• Ischemia 33%
• Electrophoretic Mobility Shift Assay 33%
• Chemokine 33%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 33%